Department of Urology, Seirei Mikatabara Hospital, 3454 Mikatabara-cho, Kita-ku, Hamamatsu, 433-8558, Japan.
Division of Urology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Int J Clin Oncol. 2018 Feb;23(1):151-157. doi: 10.1007/s10147-017-1184-0. Epub 2017 Aug 30.
The aim of this study was to investigate the prognostic significance of multiple preoperative laboratory abnormalities in upper urinary tract urothelial carcinoma (UUTUC) patients.
This study included a total of 135 consecutive patients with clinically localized UUTUC who underwent radical nephroureterectomy (RNU). The impact of several preoperative blood-based markers in addition to conventional clinical factors on extravesical recurrence-free survival (eRFS) in these patients was retrospectively evaluated.
Despite the lack of a significant correlation between conventional clinical factors and any of the postoperative pathologic parameters, preoperative laboratory abnormalities were shown to have a significant impact on some pathological factors reflecting an aggressive phenotype as follows-C-reactive protein (CRP) level on pathological stage, De Ritis (aspartate transaminase/alanine transaminase) ratio on nodal involvement, and neutrophil-lymphocyte ratio (NLR) on pathological stage. During the observation period of this study (median 36.1 months), extravesical disease recurrence was detected in 44 (32.6%) of the 135 patients with a 5-year eRFS rate of 62.1%. Of several factors examined, the CRP level, De Ritis ratio, and NRL were significantly correlated with eRFS on univariate analysis. Of these significant factors, the De Ritis ratio and NRL were identified as independent predictors of eRFS on multivariate analysis. Moreover, there were significant differences in eRFS according to the positive numbers of these two independent risk factors.
These findings suggest that it is important to consider laboratory abnormalities, particularly the De Ritis ratio and NLR, to predict disease recurrence following RNU in patients with clinically localized UUTUC.
本研究旨在探讨上尿路上皮癌(UUTUC)患者多种术前实验室异常的预后意义。
本研究共纳入 135 例接受根治性肾输尿管切除术(RNU)的局限性 UUTUC 患者。回顾性评估了除常规临床因素外,几种术前血液标志物对这些患者的尿路上皮外无复发生存(eRFS)的影响。
尽管常规临床因素与任何术后病理参数之间缺乏显著相关性,但术前实验室异常与反映侵袭性表型的一些病理因素具有显著相关性,如下:CRP 水平与病理分期、De Ritis(天冬氨酸转氨酶/丙氨酸转氨酶)比值与淋巴结受累、中性粒细胞与淋巴细胞比值(NLR)与病理分期有关。在本研究的观察期内(中位数 36.1 个月),135 例患者中有 44 例(32.6%)发生尿路上皮外疾病复发,5 年 eRFS 率为 62.1%。在单因素分析中,几个检查因素中,CRP 水平、De Ritis 比值和 NLR 与 eRFS 显著相关。在这些显著因素中,De Ritis 比值和 NLR 被确定为 eRFS 的独立预测因素。此外,根据这两个独立危险因素的阳性数量,eRFS 存在显著差异。
这些发现表明,考虑实验室异常,特别是 De Ritis 比值和 NLR,对于预测接受根治性肾输尿管切除术后局限性 UUTUC 患者的疾病复发很重要。